The Liver Meeting 2019-Precision Medicine and Patients at Risk for Drug-induced Liver Injury*

Precision Medicine and Patients at Risk for Drug-induced Liver Injury*

Video Transcription

Video Summary

In the video, a clinician presents a complex case of a 56-year-old man with unexplained liver injury following antibiotic treatment. The discussion emphasizes the challenges in diagnosing idiosyncratic drug-induced liver injury (DILI) and the limitations of current genetic testing in predicting and preventing these adverse reactions. The clinician explores the role of precision medicine in understanding DILI, highlighting the need for more reliable biomarkers and individualized approaches to treatment and prognosis. Emphasis is placed on ongoing research efforts to improve diagnostic tools and enhance patient outcomes in the context of DILI. The video concludes with a call for further studies to advance the application of precision medicine in the management of DILI.

Asset Caption

Presenter: Robert Fontana

Keywords

clinician

complex case

liver injury

antibiotic treatment

idiosyncratic drug-induced liver injury

precision medicine